A new HIV-prevention drug is showing promising signs, but it's difficult to find in Africa and beyond
Demand for lenacapavir is far outstripping supply in Uganda, other parts of Africa and all over the world. U.S. regulators on Monday approved a generic version for sale in low-income countries.
⬅ Back home Read full article ➡